The table below shows Ensysce Biosciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$961.00K
$493.10K
$1.37M
$1.32M
$3.42M
$181.80K
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$3.35M
$2.95M
$1.92M
$1.89M
$1.69M
$947.23K
SG&A
ENSC annual revenue (10-K history)
Ensysce Biosciences, Inc. reported annual revenue of $5.07M for fiscal year 2025. That is down 2.8% from $5.21M in fiscal 2024. Over the 6 fiscal years shown, annual revenue grew from $3.93M (FY 2020) to $5.07M. Figures come from the company's audited annual reports as filed with the SEC.